SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

EBSSell

Emergent BioSolutions Inc.

Donald W Degolyer · Director

$126K−13.7%Oct 7
EBSSell

Emergent BioSolutions Inc.

Paul Anthony Williams · SVP, Products Business

$25K−1.9%Jul 2
EBSSell

Emergent Biosolutions Inc.

Sujata Tyagi Dayal · Director

$116K−12.0%May 4
EBSSell

Emergent Biosolutions Inc.

Donald W Degolyer · Director

$130K−11.0%May 4
EBSSell

Emergent Biosolutions Inc.

Keith Katkin · Director

$128K−14.0%May 4
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$144K−18.0%May 4
EBSSell

Emergent Biosolutions Inc.

Ronald Richard · Director

$263K−18.0%Dec 9
EBSBuy

Emergent Biosolutions Inc.

Joseph C Papa · President and CEO

$350K+21.0%May 15
EBSSell

Emergent Biosolutions Inc.

Donald W Degolyer · Director

$273K−18.0%Nov 14
EBSSell

Emergent Biosolutions Inc.

Marvin L White · Director

$171K−21.0%Nov 13
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$61K−16.0%Jun 6
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$30K−7.0%Jul 24
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$37K−6.0%Jun 13
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$71K−14.0%May 25
EBSBuy

Emergent Biosolutions Inc.

Richard S Lindahl · EVP and CFO

$112K+8.0%Nov 15
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$177K−18.0%May 27
EBSSell

Emergent Biosolutions Inc.

Sue Bailey · Director

$754K−25.0%Mar 8
EBSSell

Emergent Biosolutions Inc.

Adam Havey · EVP, Business Operations

$3.7M−49.0%Mar 3
EBSSell

Emergent Biosolutions Inc.

Robert Kramer · President and CEO

$5.4M−25.0%Feb 9
EBSSell

Emergent Biosolutions Inc.

Robert Kramer · President and CEO

$2.7M−15.0%Jan 22
EBSSell

Emergent Biosolutions Inc.

Robert Kramer · President and CEO

$2.0M−12.0%Jan 19
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$3.6M−1.0%Nov 12
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair

$3.6M−1.0%Nov 4
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$2.5M−1.0%Sep 25
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$4.1M−1.0%Sep 18
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$4.1M−1.0%Sep 11
EBSSell

Emergent Biosolutions Inc.

Louis W Sullivan · Director

$3.2M−40.0%Sep 4
EBSSell

Emergent Biosolutions Inc.

Sue Bailey · Director

$599K−13.0%Aug 19
EBSSell

Emergent Biosolutions Inc.

Zsolt Harsanyi · Director

$884K−21.0%Aug 18
EBSSell

Emergent Biosolutions Inc.

George A Joulwan · Director

$745K−18.0%Aug 12
EBSSell

Emergent Biosolutions Inc.

Ronald Richard · Director

$825K−43.0%Aug 11
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$130K−7.0%Aug 11
EBSSell

Emergent Biosolutions Inc.

Ronald Richard · Director

$575K−61.0%Jun 5
EBSSell

Emergent Biosolutions Inc.

Sue Bailey · Director

$466K−12.0%Jun 5
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$348K−23.0%May 27
EBSSell

Emergent Biosolutions Inc.

Jerome M Hauer · Director

$373K−30.0%May 27
EBSSell

Emergent Biosolutions Inc.

Kathryn C Zoon · Director

$141K−10.0%May 14
EBSSell

Emergent Biosolutions Inc.

Zsolt Harsanyi · Director

$405K−17.0%May 13
EBSSell

Emergent Biosolutions Inc.

George A Joulwan · Director

$170K−6.0%May 13
EBSSell

Emergent Biosolutions Inc.

Ronald Richard · Director

$672K−51.0%May 6
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$3.0M−1.0%May 1
EBSSell

Emergent Biosolutions Inc.

Ronald Richard · Director

$616K−32.0%Apr 29
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$2.7M−1.0%Apr 24
EBSSell

Emergent Biosolutions Inc.

Adam Havey · EVP, Business Operations

$2.5M−52.0%Apr 21
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$1.2MApr 20
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$2.2MApr 15
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$3.8M−1.0%Apr 10
EBSSell

Emergent Biosolutions Inc.

Fuad El-Hibri · Chair and 10% owner

$2.6M−1.0%Apr 8
EBSSell

Emergent Biosolutions Inc.

Adam Havey · EVP, Business Operations

$478K−19.0%Apr 8
EBSSell

Emergent Biosolutions Inc.

Sean Kirk · EVP, Manufacturing, Tech Ops

$966K−56.0%Apr 8

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.